サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1545523

デジタルPCRの世界市場

Digital PCRs

出版日
ページ情報
英文 196 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
デジタルPCRの世界市場
出版日: 2024年09月02日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 196 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

デジタルPCRの世界市場は2030年までに3億7,120万米ドルに達する見込み

2023年に2億1,720万米ドルと推定されたデジタルPCRの世界市場は、2023年から2030年にかけてCAGR 8.0%で成長し、2030年には3億7,120万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである基礎調査アプリケーションは、CAGR 8.0％を記録し、分析期間終了までに1億5,070万米ドルに達すると予測されます。臨床診断アプリケーション分野の成長率は、分析期間中CAGR 8.5％と推定されます。

米国市場は5,980万米ドルと推定、中国はCAGR7.3%で成長すると予測

米国のデジタルPCR市場は、2023年に5,980万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに5,670万米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは7.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.3％と6.5％と予測されています。欧州では、ドイツがCAGR約6.4%で成長すると予測されています。

世界のデジタルPCR市場動向と促進要因まとめ

デジタルPCRとは何か、なぜ分子生物学のゲームチェンジャーなのか？

デジタルPCR（dPCR）は、DNAまたはRNAを定量し増幅するために使用される高精度で高感度な分子技術です。この方法はサンプルを多くの個別の反応に分割します。PCR増幅後、各パーティションは標的配列の有無を決定するために分析され、従来のPCR法よりも正確な定量が可能になります。デジタルPCRは参照標準や内部対照を必要としない絶対定量を提供するため、低存在量の標的の検出、遺伝子発現レベルの評価、遺伝的変異の解析などの信頼性が著しく向上します。この技術は、正確な測定が重要な臨床診断、個別化医療、環境生物学において特に価値が高いです。

技術の進歩はデジタルPCRの能力をどのように洗練させているか？

デジタルPCRにおける最近の技術的進歩には、流体力学、マイクロ流体工学、ソフトウェア解析の改良が含まれ、これらのシステムの精度、使いやすさ、スループットを向上させています。液滴デジタルPCR（ddPCR）やチップベースのdPCRのような革新は、分析するパーティション数を増加させることにより、より高い感度と精度を提供し、この分野に革命をもたらしました。これらの進歩により、研究者は血液サンプル中の低濃度腫瘍DNAのような希少なDNAターゲットをこれまでにない精度で検出することができます。さらに、自動化とリアルタイムのデータ解析ソフトウェアの統合により、ヒューマンエラーの可能性が減少し、ワークフローが合理化されるため、デジタルPCRはハイスループット環境におけるルーチン使用のための強固なツールとなります。

どのようなアプリケーションがデジタルPCR技術に牽引されているか？

デジタルPCRは基礎研究を超えて様々なアプリケーションでますます重要になってきています。臨床診断では、がん変異や感染症の早期検出、最小残存疾患のモニタリング、治療効果の追跡などに使用され、患者の治療計画や転帰に直接影響を与えることができます。環境モニタリングの分野では、dPCRは土壌や水サンプル中の低レベルの病原体や遺伝子組み換え作物の検出を可能にします。さらに、急成長しているリキッドバイオプシーの分野では、dPCRは循環腫瘍DNAの検出と定量化によって非侵襲的ながん診断に役立ち、早期診断、予後予測、疾患モニタリングのための強力なツールを提供します。各アプリケーションは、dPCRの高感度と高精度の恩恵を受けており、これらの重要な研究・応用分野への統合を推進しています。

何がデジタルPCR市場の成長を促進するか？

デジタルPCR市場の成長は、強固な定量技術を必要とする正確な分子診断と個別化医療への需要の増加を含む、いくつかの要因によって駆動されます。遺伝子疾患とがんの有病率の上昇は、リキッドバイオプシーの認知度と臨床採用の増加と相まって、デジタルPCR技術への需要をさらに煽る。dPCRセットアップの効率を高めコストを削減する技術革新も市場拡大に寄与しています。さらに、食品安全、環境モニタリング、農業生物学におけるdPCRの応用範囲の広がりは、その汎用性と有効性を強調し、様々な分野からの投資を引き付けています。これらの要因は、デジタルPCRシステムの継続的な改良と精密診断の重視の高まりと相まって、分子生物学と臨床診断の将来における重要性を反映し、dPCR市場が拡大し続けることを確実にしています。

調査対象企業の例（全46件）

  • Bio-Rad Laboratories, Inc.
  • Fluidigm Corporation
  • Formulatrix
  • JN Medsys
  • RainDance Technologies, Inc.
  • Stilla Technologies
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP11555

Global Digital PCRs Market to Reach US$371.2 Million by 2030

The global market for Digital PCRs estimated at US$217.2 Million in the year 2023, is expected to reach US$371.2 Million by 2030, growing at a CAGR of 8.0% over the analysis period 2023-2030. Basic Research Application, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$150.7 Million by the end of the analysis period. Growth in the Clinical Diagnostics Application segment is estimated at 8.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$59.8 Million While China is Forecast to Grow at 7.3% CAGR

The Digital PCRs market in the U.S. is estimated at US$59.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$56.7 Million by the year 2030 trailing a CAGR of 7.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.3% and 6.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.

Global Digital PCRs Market - Key Trends and Drivers Summarized

What Is Digital PCR and Why Is It a Game-Changer in Molecular Biology?

Digital PCR (dPCR) is a highly precise and sensitive molecular technique used to quantify and amplify DNA or RNA. This method partitions a sample into many individual reactions. After PCR amplification, each partition is analyzed to determine the presence or absence of the target sequence, allowing for more accurate quantification than traditional PCR methods. Digital PCR provides absolute quantification without the need for reference standards or internal controls, which significantly enhances its reliability for detecting low-abundance targets, assessing gene expression levels, and analyzing genetic variations. This technology is particularly valuable in clinical diagnostics, personalized medicine, and environmental biology, where precise measurements are crucial.

How Are Technological Advancements Refining Digital PCR Capabilities?

Recent technological advancements in digital PCR include improvements in fluid dynamics, microfluidics, and software analytics, which enhance the accuracy, usability, and throughput of these systems. Innovations such as droplet digital PCR (ddPCR) and chip-based dPCR have revolutionized the field by increasing the number of partitions analyzed, thereby providing greater sensitivity and precision. These advancements allow researchers to detect rare DNA targets, such as low-abundance tumor DNA in blood samples, with unprecedented accuracy. Furthermore, the integration of automation and real-time data analysis software reduces the potential for human error and streamlines the workflow, making digital PCR a robust tool for routine use in high-throughput settings.

What Applications Are Driven by Digital PCR Technology?

Digital PCR is becoming increasingly crucial across various applications beyond basic research. In clinical diagnostics, it is used for early detection of cancer mutations and infectious diseases, monitoring minimal residual disease, and tracking treatment efficacy, which can directly influence patient treatment plans and outcomes. In the field of environmental monitoring, dPCR enables the detection of low-levels of pathogens or GMOs in soil and water samples. Additionally, in the burgeoning field of liquid biopsy, dPCR helps in non-invasive cancer diagnostics by detecting and quantifying circulating tumor DNA, offering a powerful tool for early diagnosis, prognosis, and disease monitoring. Each application benefits from dPCR’s high sensitivity and precision, driving its integration into these critical areas of study and application.

What Drives the Growth in the Digital PCR Market?

The growth in the digital PCR market is driven by several factors, including the increasing demand for precise molecular diagnostics and personalized medicine, which require robust quantitative techniques. The rising prevalence of genetic disorders and cancer, coupled with growing awareness and clinical adoption of liquid biopsies, further fuels the demand for digital PCR technology. Technological innovations that enhance the efficiency and reduce the cost of dPCR setups also contribute to market expansion. Additionally, the broadening applications of dPCR in food safety, environmental monitoring, and agricultural biology emphasize its versatility and effectiveness, attracting investment from various sectors. These factors, combined with the ongoing improvements in digital PCR systems and a growing emphasis on precision diagnostics, ensure that the market for dPCR will continue to expand, reflecting its critical importance in the future of molecular biology and clinical diagnostics.

Select Competitors (Total 46 Featured) -

  • Bio-Rad Laboratories, Inc.
  • Fluidigm Corporation
  • Formulatrix
  • JN Medsys
  • RainDance Technologies, Inc.
  • Stilla Technologies
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Digital PCRs - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Precision Medicine Propels Adoption of Digital PCRs
    • Increasing Use of Digital PCR in Cancer Diagnostics Expands Market Opportunities
    • Expanding Applications of Digital PCR in Infectious Disease Testing Sets the Stage for Market Growth
    • Rising Adoption of Digital PCRs in Liquid Biopsy Technologies Drives Market Expansion
    • Increasing Use of Digital PCRs in Agricultural Biotechnology Bodes Well for Market Growth
    • Growing Focus on Non-Invasive Prenatal Testing (NIPT) Spurs Adoption of Digital PCRs
    • Growing Use of Digital PCR in Environmental Testing Expands Addressable Market
    • Expansion of Digital PCR in Food Safety Testing Generates Market Opportunities
    • Rising Prevalence of Genetic Disorders Sets the Stage for Growth in Digital PCR Market
    • Development of Portable Digital PCR Devices Bodes Well for Market Expansion
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Pharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Basic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Basic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Basic Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Clinical Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Digital PCRs Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Digital PCRs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Digital PCRs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Digital PCRs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Digital PCRs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Digital PCRs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Digital PCRs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 118: Rest of Europe 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Digital PCRs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 127: Asia-Pacific 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Digital PCRs by End-Use - Research Institutes, Pharmaceutical Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of World 16-Year Perspective for Digital PCRs by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Pharmaceutical Companies and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Digital PCRs by Offering - Instruments, Consumables and Services - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Digital PCRs by Offering - Instruments, Consumables and Services Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Digital PCRs by Offering - Percentage Breakdown of Value Sales for Instruments, Consumables and Services for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Digital PCRs by Application - Basic Research, Clinical Diagnostics and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Digital PCRs by Application - Percentage Breakdown of Value Sales for Basic Research, Clinical Diagnostics and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION